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Abstract 
 
Background: No condition-specific patient-reported outcome measures exist for patients 
with abdominal aortic aneurysm (AAA). The aim of this work was to develop three 
questionnaires to assess quality of life (QoL), symptoms and treatment satisfaction in patients 
with AAA. 
 
Methods: Semi-structured interview techniques were used to explore patients’ experiences of 
having AAA in a series of focus groups and in-depth interviews. The information gathered was 
used to inform design and selection of items for the new tools, with the overall structure of 
the new questionnaires based upon tools developed previously for patients with diabetes and 
other conditions.  
 
Results: 54 patients (51 men; 3 women; mean age 71.9yrs) were recruited from 4 NHS Trusts 
to participate in focus groups or interviews, either whilst under surveillance or following AAA 
repair (using open or endovascular techniques). The AneurysmDQoL is a 22-item, 
individualised measure of the impact of AAA on patients’ QoL.  It has 20 domains chosen 
specifically for their relevance to patients with AAA with a further 2 overview items to assess 
overall QoL and the impact of AAA on QoL.  The AneurysmSRQ is a 44-item, aneurysm-specific 
measure assessing physical and psychological symptoms reported by patients with AAA.  The 
AneurysmTSQ is a 12-item condition-specific measure of treatment satisfaction, with 
subscales suitable for pre- and post-surgical intervention.  
 
Conclusion: The iterative development process reported here has confirmed that these three 
new tools have good face and content validity for patients with AAA.   Psychometric analyses 
assessing structure and construct validity of the tools will be reported separately. 
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Introduction 
 
In the UK, abdominal aortic aneurysms (AAA) affect 5-10% of men and 1.5% of women between 
the ages of 65 and 79 and constitute a significant cause of mortality in this age group.1  Due to 
the risk of rupture, patients diagnosed with AAA usually undergo elective repair once the 
aneurysm reaches threshold size (5.5cm).  Techniques of AAA repair have evolved significantly 
in recent years with large numbers now treated with endovascular repair (EVAR) rather than 
open repair (OR).  As a result of these advances and rigorous Quality Improvement 
Programmes, surgical morbidity and mortality have fallen dramatically and these parameters 
are therefore less useful than previously as the sole markers of surgical quality.2 Additionally 
and importantly, measures of quality of life (QoL), symptoms and treatment satisfaction allow 
evaluation of outcomes from the patients’ perspectives.  This allows clinicians to target those 
issues that are most important to patients and strive for even higher quality care rather than 
simply avoiding adverse outcomes.  For this reason the last few years have seen the UK 
Department of Health embark on a nationwide initiative to encourage the use of patient-
reported outcome measures (PROMs), both in the surgical specialties generally and more 
specifically in aortic aneurysm surgery.3 4    
 
In the absence of a validated aneurysm-specific QoL measure, all previous studies of QoL in 
patients with AAA have used generic tools.  Systematic review of these studies demonstrated 
that there was no clear consensus about the overall impact of AAA (or AAA repair) on QoL.5   
Meta-analysis of existing data did provided some additional clarification, suggesting that QoL 
may be negatively impacted after AAA repair. 1  However, the pattern of change over time 
(particularly beyond 12 months post-intervention) and any differences between OR and EVAR 
may have been obscured by the use of generic tools and heterogeneity of data in the included 
studies.  Furthermore, very little is known about symptoms experienced or treatment 
satisfaction in these patients. 
 
The aim of this work was to design three new condition-specific questionnaires based on the 
experiences of patients with AAA to provide robust, separate assessments of QoL, symptoms, 
and treatment satisfaction for use in clinical practice, audit and research.  
 
 
 
Methods 
 
Recruitment of patients 
 
Patients were recruited from 4 English NHS Trusts: St George’s University Hospitals NHS 
Foundation Trust (London), North Bristol NHS Trust, Norfolk and Norwich University 
Hospitals NHS Trust and Worcestershire Acute Hospitals NHS Trust.   All participants had 
undergone AAA repair within the preceding 24 months (OR or EVAR) or were enrolled in 
preoperative surveillance with an aneurysm that was below the threshold size for 
intervention.  Both men and women were invited and there was no age constraint.  Only 
English-speaking patients were invited to take part. 
 
Focus groups 
 
Patients were identified using a purposive sampling technique (maximum variation) and 
assigned to focus groups with similar patients (i.e. all pre-intervention or OR or EVAR).   This 
was done to prevent confusion between participants who had experienced different forms of 
treatment.   The National Research Ethics Service (NRES Committee – London Chelsea – 
11/LO/1416) approved the process of patient recruitment prior to the start of the study and 
patients provided written consent at each stage. 
 
The number of focus groups was determined using a ‘theme-saturation’ model, which dictates 
that no further focus groups are necessary once there are no new themes being presented by 
participants.6  Focus groups were moderated by a trainee vascular surgeon (GP) and a health 
psychologist with extensive experience in questionnaire design (CB).   A semi-structured 
format was used to explore patients’ experiences in relation to QoL, symptoms and treatment 
satisfaction at each stage in the treatment pathway using open-ended questions. This 
structure included diagnosis, surveillance, preoperative investigations and, where applicable, 
intervention, recovery and follow-up.  More sensitive topics (such as bowel or sexual 
function) were specifically avoided during focus groups to avoid causing embarrassment to 
participants.   Written notes and audio recordings were made during each session to allow 
subsequent transcription.   
 
Transcripts underwent content analysis to allow identification of the themes raised by group 
participants.   Individual issues were listed and grouped into themes, with continual re-
evaluation after each group and addition of new issues/themes as they emerged.  Newly 
identified themes were then re-explored in greater depth at subsequent focus groups.  This 
process clarified when theme-saturation had been reached and resulted in a single list of all 
aspects of QoL, symptoms and treatment satisfaction that had been raised by the participants. 
(Table 2).  
 
Questionnaire design 
 
The themes identified during the focus groups then determined the aspects of QoL, symptoms 
and treatment satisfaction that were included in drafts of the three new questionnaires.  To 
minimize the need for linguistic validation, the wording and structure of questions in the new 
tools was based upon items from existing questionnaires previously developed with other 
patient groups and validated by CB as described below. The number of items in each of the 
new questionnaires was not predetermined, but instead resulted from inclusion of suitable 
items from a pre-existing question bank to address the domains relevant to patients with 
AAA.  If no previous bank item existed (or could be adapted) to cover a QoL domain raised in 
the focus groups, a new item was created with specialist linguistic input before being tested in 
interviews. 
 
 
Aneurysm-Dependent Quality of Life Questionnaire 
The overall format of the AneurysmDQoL and many of the individual items were based upon 
those in the Audit of Diabetes-Dependent Quality of Life (ADDQoL) and associated tools.  
These are widely used questionnaires designed for use by people with diabetes and other 
conditions and the ADDQoL has been linguistically validated in more than 60 languages. 7-15 
Though these are written-response questionnaires and condition-specific, they were all 
influenced by the SEIQoL (Schedule for the Evaluation of Individual QoL) interview 
methodology.16 This allows respondents to indicate how important various aspects of their 
life are to them, thereby providing an individualised measure of QoL.   Respondents are also 
able to indicate if they consider an item to be inapplicable to them (e.g. if a question asks 
about family and the respondent does not have any family).  
 
In part (a) of each –DQoL item, the relevant domain is introduced using a specific statement, 
followed by five possible response options.  In part (b) of each item, respondents are asked to 
indicate how important that domain is to their QoL, using a four-point scale (fig 1). A 
‘weighted impact’ score for each item is then derived by multiplying part (a) and part (b) 
scores together. 
 
Figure 1: Example of question format and scoring for the Aneurysm-Dependent Quality of Life 
Questionnaire (AneurysmDQoL) (scoring shown for information only – not usually visible 
 
In addition to items asking about specific aspects of life, the AneurysmDQoL also includes two 
broad overview items.  The first asks respondents to rate their present QoL and the second 
asks how their quality of life would be if they had not had an aneurysm.  
 
Aneurysm Symptom Rating Questionnaire 
Question format of the AneurysmSRQ was based on tools developed previously for patients 
with a number of chronic diseases. 17 18  
 
In the first part of each question, respondents are asked to indicate whether they had 
experienced a particular symptom at all in recent weeks (defined as ‘about four weeks’).  For 
those who had experienced that symptom, the second part of the question asks how much it 
had bothered them. Responses to the second part of the question are given using a 4-point 
scale (Fig 2).  
 
Figure 2: Example item from the Aneurysm Symptom Rating Questionnaire (AneurysmSRQ) 
Aneurysm Treatment Satisfaction Qquestionnaire 
The AneurysmTSQ was based on the Diabetes Treatment Satisfaction Questionnaire (DTSQ) 
and associated questionnaires for other conditions. 19-24  For each question in the 
AneurysmTSQ, patients are asked to respond using a 7-point scale where a higher score 
indicates greater satisfaction with treatment (Fig. 3). 
 
Figure 3: Example item from the Aneurysm Treatment Satisfaction Questionnaire 
(AneurysmTSQ) 
 
Since questionnaires were to be tested in patient interviews, all patient-identified issues were 
included in the initial drafts even if they were considered to be uncommon or unrelated to 
having an aneurysm, or had only been mentioned by one or two participants.   Several 
additional items were also incorporated into the drafts to assess more sensitive symptoms 
including bowel function and sexual function, which may not have been mentioned by 
patients in a focus-group setting, but where there is evidence to suggest that AAA or its repair 
may have a negative impact. 25-27 
 
Pilot interviews and questionnaire refinement 
 
In the next stage of development, the draft questionnaires were refined through in-depth 
interviews.  In these interviews, participants were asked to work through each of the 
questionnaires in turn, reading the questions out and ‘thinking aloud’ so that interviewers 
could see when they were having difficulty reading or comprehending an item.  This 
technique has been well proven over many years of developing similar tools.7 28 Participants 
were also given the opportunity to identify any additional issues that they felt had not been 
covered in the new tools. 
 
Results 
 
Nine focus groups were held during the initial phase of development (6 EVAR; 2 OR; 1 
surveillance).  In total, these involved 41 patients with AAA, with between 3 and 6 
participants in each group. Though the majority of groups were with EVAR patients for 
logistic reasons, theme saturation suggested no further groups were necessary for either OR 
or surveillance patients.  Thirteen in-depth interviews were then carried out during the 
subsequent refinement process. (Table 1) 
 
 
Aneurysm-Dependent Quality of Life Questionnaire (AneurysmDQoL) 
 
In all of the focus groups for patients who had already undergone aneurysm repair (OR or 
EVAR), there were reports of AAA-related issues that could have negatively impacted their 
QoL (Table 2). Preoperative anxiety was particularly prevalent, with participants mentioning 
this spontaneously in 8 of the 9 focus groups and describing feelings of having a ‘ticking time-
bomb inside’. Anxiety about surgical intervention was also noted. 
 
Participants in 2 groups (both EVAR) reported feelings of relief once their aneurysm was 
repaired, using phrases such as ‘I felt happy to be alive’, ‘I had a near miss’ and ‘it was as if the 
bomb had been defused’.  One patient (EVAR group) also said that they valued each day more 
since having the aneurysm repaired.  However, relief of anxiety following intervention was 
certainly not universal.  With many having experienced no preoperative symptoms, 
participants in 4 groups (3 EVAR, 1 OR) expressed concerns about the possibility of other 
occult illnesses and how they would ever know if any ‘problem’ were to arise with their 
aneurysm repair.  
  
Another commonly arising theme was the impact of restricted activity on QoL.  This was 
mentioned in 6 groups (all EVAR) and largely related to patients feeling that they had to limit 
their physical activity (as opposed to being physically incapable of doing things).  In a small 
subset of patients (e.g. commercial drivers) there were financial implications due to being 
prohibited from working with an untreated aneurysm. Other notable QoL themes raised by 
participants included failure to return to preoperative level of well-being following 
intervention; impact on relationships with family members; and the fact that some patients 
felt unprepared for the severity of the operation or complications when they arose. 
 
The initial draft of the AneurysmDQoL contained 25 items in total.  Following the first 2 
overview items, there were 22 domain-specific items addressing the impact of AAA on 
multiple patient-identified aspects of life of importance for QoL (Table 2). The final item on 
the questionnaire was a free-text question, to allow patients to identify any other ways in 
which QoL is impacted by having had AAA. 
 
In-depth interviews resulted in several minor modifications to the AneurysmDQoL.  To 
improve patients’ understanding of the stem question, the wording was changed from ‘If I had 
not had an aneurysm, my quality of life would be…’ to ‘If I had never had an aneurysm…’. This 
was because a number of participants misinterpreted this to be about how their quality of life 
would be if they had not had an aneurysm repair, rather than the actual condition. For 
example, some patients commented that if they had not had an aneurysm repair they would 
be dead. The change to the wording improved participants’ understanding that the item was 
asking them to consider their QoL at time of questionnaire completion and how they feel this 
would be different if they had never had an aneurysm (whether repaired or not).  Wording of 
the discomfort item was also changed, with participants finding the words ‘physical 
discomfort’ easier to understand than ‘bodily discomfort’.    
 
In a draft version of the AneurysmDQoL, there were three items relating to cognitive function, 
which asked about ‘memory’, ‘ability to concentrate’ and ‘ability to think quickly and clearly’.  
However, a composite form of this question ultimately proved to detect as much impact as the 
individual items combined and the composite item was therefore retained (Item 22, Appendix 
1).  
 
None of the participants identified any additional aneurysm-related QoL issues that were not 
already covered by the questionnaire.  The final version contained 23 domain-specific items 
plus the single free-text question about any other ways that QoL is affected.  One domain 
specific item (‘The amount I value each day’) was ultimately removed during validation (to be 
reported separately), resulting in 22 domain specific items. 
 
Aneurysm Symptom Rating Questionnaire (AneurysmSRQ) 
 
During focus groups, patients reported a wide range of symptoms that they attributed to their 
aneurysm or its repair (Table 2).  The most common of these was pain, with leg pain, lower 
back pain, abdominal pain and buttock pain being the most common (reported in 7, 5, 4 and 4 
groups respectively).  Other lower limb symptoms included swelling, numbness, weakness 
and heaviness.  In addition to pain and limb symptoms, there were also a number of more 
generalized symptoms that were frequently mentioned.  Participants in 7 of the 8 
postoperative groups (all 6 EVAR groups and 1 OR group) commented on a feeling of marked 
lethargy for many months post-intervention.  Low mood and weight loss were also noted in 4 
groups each, with general weakness, decreased activity, profuse sweating, significant bruising, 
and poor appetite each mentioned in at least two groups. 
 
The initial draft of the AneurysmSRQ comprised 46 items in total: 43 asking about the specific 
physical, mental and psychological symptoms that were identified during focus groups and 3 
free-text items allowing patients to identify any additional symptoms that had not been 
covered elsewhere.   Interviews also provided the opportunity to discuss more sensitive 
topics that were not raised during focus groups.  The interviews confirmed that these issues 
were of concern to patients and warranted inclusion in the AneurysmSRQ with more than 
40% of interviewees reporting some upset in gastrointestinal function and over 60% 
reporting negative changes to their sex-life.  The interview stage also resulted in the 
amendment or removal of several items that participants found difficult to understand or 
were not deemed relevant. These included those relating to general muscle pains, 
hallucinations, lumps under the skin and wound infection.  A number of completely new items 
were also added after being identified as important by interviewees.  These included 
avoidance of sexual activity (as distinct from problems with sexual function and loss of 
interest in sex which were in the original draft), feeling faint/lightheaded, difficulty thinking 
quickly and clearly and changes in bowel function.  Furthermore, items were reordered to 
group symptoms into themes (e.g. gastrointestinal symptoms or pain etc.) so that the 
questionnaire followed a more logical sequence.  The final version contained 44 items and 2 
free-text items for any additional symptoms. 
Aneurysm Treatment Satisfaction Questionnaire (AneurysmTSQ) 
 
When it came to discussion of treatment satisfaction, a range of issues were highlighted 
(Table 2), though the most frequently reported concern was that patients didn’t feel it had 
been made clear to them how serious their condition was.  This related to a lack of 
information about likely side-effects (as opposed to complications covered in the 
preoperative consent process) and how much intervention might affect them both mentally 
and physically.  Similarly, patients in six of the nine focus groups felt that that they had been 
given insufficient information about whether they should avoid physical exertion and 
whether certain activities, such as air travel, were safe pre- or postoperatively.  Patients also 
frequently commented (6 of 9 groups) that they had not been given any choice about the type 
of intervention they would have for their aneurysm (i.e. OR or EVAR) and one elderly woman 
patient was distressed that she had had an OR and would have preferred EVAR.  Some were 
not concerned by the lack of choice, however, and felt that the surgeon knew best and that 
they would not have minded what sort of operation they had. Other reported factors included 
insufficient time for consent, little contact with the surgeon and a lack of feedback about scan 
results.  Interestingly, however, patients generally described feeling positively reassured by 
follow-up scans and clinic visits, rather than seeing them as a burden or source of anxiety.  
 
In the AneurysmTSQ, patients are asked to evaluate their experiences of AAA treatment 
(including any monitoring or surveillance) over the preceding few weeks. The initial draft 
contained 16 items in total.  Fifteen of these items related to specific elements of treatment 
and monitoring, including overall treatment, convenience, discomfort, information, feedback, 
support, follow-up, demands of treatment and monitoring, understanding and satisfaction 
with type of operation (i.e. OR or EVAR). As in the AneurysmDQoL and AneurysmSRQ, there 
was also a final open question to allow respondents to mention any particular areas of 
satisfaction or dissatisfaction that had not already been covered.   
 
Four items were removed from the AneurysmTSQ following in-depth interviews.  Three of 
these were poorly understood by patients or unnecessarily repetitive and related to demands 
of treatment; flexibility of treatment and how well they felt the operation had worked.  The 
fourth item to be removed asked about whether patients would chose to undergo the same 
type of intervention again should it become necessary.  Unfortunately, this was found to cause 
concern amongst participants as they felt it was suggesting that further intervention was 
likely.  It was also decided that this aspect of satisfaction was covered in a separate item that 
asked whether patients would encourage others to have the same kind of treatment for their 
aneurysm.   
 
Once again, despite prompting, none of the interviewees highlighted any sources of 
satisfaction or dissatisfaction that had not already been covered by the questionnaire.  The 
final version therefore contained 11 items and a single open question about any unmentioned 
issues. 
 
Discussion 
 
The focus groups and interviews provided significant new qualitative data relating to 
patients’ experiences of AAA and AAA repair.  This has identified the aspects of QoL, 
symptoms and treatment satisfaction that are most relevant to these patients and led to the 
development of three comprehensive new outcome measures.  
 
Over and above the health status outcomes described elsewhere in the literature, patients 
involved in this study have identified a number of previously unrecognized QoL issues 
associated with AAA.   These included persistent postoperative anxiety in both EVAR and OR 
cohorts, impact of restrictions of activity, avoidance of sexual activity, impact on family life 
and loss of financial independence.  Importantly, with the exception of anxiety, these newly 
identified themes are not addressed at all by the generic measures of health status (such as 
the SF36 and EQ-5D) that have commonly been used to assess patient-reported outcomes in 
this patient group. 29 30   This emphasizes the need for the new tools - and for further study 
using these new tools - so that clinicians and patients can together make truly informed 
decisions about their care. 
 
Patients described a wide range of symptoms and aspects of treatment that might influence 
their QoL.  Whilst some of these symptoms may not be directly related to AAA or its repair, a 
conscious decision was made to retain all symptoms that had been mentioned by patients in 
the questionnaire until a much larger data collection has been undertaken.  At that point it 
may be possible to remove items if there is robust evidence that they are unrelated to AAA. 
 
Whilst postoperative pain – particularly affecting the lower limbs - has been described 
previously, what was unexpected here was that persistent pain and lethargy seemed to be 
reported as frequently after EVAR as after OR.  This differs from previous evidence suggesting 
that OR has greater long-term physical impact than EVAR. 31 Whilst the data presented here 
are qualitative rather than quantitative, they certainly suggest that this aspect of recovery 
after AAA repair warrants further investigation. 
 
The suggestion that AAA is a largely asymptomatic condition prior to intervention32 is 
supported by the fact that most of the patients in our cohort did not describe overt physical 
symptoms preoperatively. However, that is not to say that having an aneurysm had no 
negative impact on their QoL during this period of surveillance.  In the absence of major 
physical symptoms, the impact of AAA on QoL appears to be centred around anxiety in the 
preoperative phase.  Though this may have been anticipated, what was less expected was that 
OR and EVAR patients reported persistent anxiety after intervention.  In the open-repair 
group, a number of patients also expressed concerns about the relative lack of follow-up and 
felt as though they had been left to cope alone very soon after a major operation.  Indeed, 
patients who had undergone EVAR generally reported feeling reassured by follow-up scans, 
rather than seeing them as a burden or a source of anxiety.  This is contrary to previous 
assumptions that repetitive follow-up after EVAR might cause patients to worry that they 
were not ‘fixed’ or that CT surveillance might lead to concerns about radiation exposure.33 34  
It also highlights the need for more detailed study of this area, since awareness of such patient 
views might influence the current trend towards more rapid hospital discharge and early 
cessation of follow-up.  At the very least it might allow clinicians to guide patients’ 
expectations more effectively. 
 
Guiding patients’ expectations about treatment is clearly a very important part of the patient-
doctor interaction, and the treatment satisfaction issues described by participants were often 
related to communication and the provision of information.  Patients were often unclear 
about the nature and severity of their condition, whether they should restrict their day-to-day 
activity, and the likelihood of side-effects and complications.   Though communication issues 
are a common source of dissatisfaction in healthcare, 35 the identification of specific 
deficiencies in this setting has highlighted clear targets for improvements in practice. 
 
Though a small number of changes were made to the newly designed questionnaires during 
the interview phase, they generally performed well from the outset. They were clearly very 
acceptable to patients and proved to have good face- and content-validity.  Items relating to 
the more sensitive topics little discussed in the focus groups also proved to be highly relevant 
and these topics therefore warrant further quantitative investigation in a larger group of 
patients.   The QoL and symptom measures are suitable for all AAA patients and validation 
(reported elsewhere) has confirmed that the Treatment Satisfaction Questionnaire has 
separate subscales suitable for patients pre- or post-intervention (and at any time-point).36 
 
Significant efforts were made to include a representative sample of patients by involving 
multiple centres and OR and EVAR patients, both pre- and post-intervention.  However, it is 
recognized that the ratio of male to female participants was higher than might be expected 
based on the natural prevalence of the condition.   This was partly because more men than 
women had undergone AAA repair within the preceding two years at the centres involved in 
the study.  The number of female participants was also limited by simple logistic 
considerations such as whether they were readily contactable or available on the dates of the 
focus groups or interviews.  Nonetheless, the deliberate retention of ‘free text’ items in the 
final versions of each questionnaire will ensure that patients have the opportunity to raise 
any issues that have not been covered elsewhere. 
 
This paper reports the design of three new questionnaires to assess QoL (AneurysmDQoL), 
symptoms (AneurysmSRQ) and treatment satisfaction (AneurysmTSQ) among patients with 
AAA.  Having been developed with patient involvement at every stage, these new 
questionnaires are believed to be highly representative of the issues experienced by these 
patients.  Psychometric evaluation (to be reported separately) has confirmed their structure, 
reliability and suitability for use in this patient group and they are now ready for wider 
clinical use in order to improve our understanding of the impact of AAA and AAA repair. 36   
 
[For access to the instruments please visit www.healthpsychologyresearch.com] 
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Table S1 Aspects of quality of life, symptoms and treatment satisfaction identified during 
focus groups 
 
No. of 
groups 
mentioni
ng 
Example quote 
Quality of life 
   Preoperative anxiety 
Fear of rupture 
Increasing anxiety as aneurysm grew 
Waiting indefinitely for intervention 
Anxiety about intervention itself 
 
8 
8 
5 
2 
2 
‘what QoL could I have with a  
time- 
    bomb inside of me’ 
‘I waited 18 months and it was 
getting 
    bigger and bigger and I was on  
    edge waiting for the results’ 
‘I didn’t worry at first, but when 
it  
    was said that action was 
needed I  
    got worried’ 
   Postoperative anxiety 4 ‘once you have one thing that 
was  
    completely symptomless you  
    wonder what else you might 
have 
    wrong with you’ 
   Restrictions of activity 4 ‘I was terrified to do anything’ 
   Impact on work 3 ‘I got through all the tests to be a  
    truck driver and they sent me 
for  
    all these tests and then doc 
said you  
    won’t get the job, you’ve got an  
    aneurysm’ 
   Relief of anxiety after operation 3 ‘When I had the operation it felt 
like 
    someone had defused the 
bomb’ 
   Impact on social life 1 ‘I find it overwhelming in a 
crowded  
    room since the operation. 
Prior to  
    that you couldn’t keep me out 
of a  
    crowded pub.’ 
‘I don’t feel sociable’ 
   Financial implications 1 Commercial driver: ‘I’m now  
    restricted to a 1 year [driving]  
    licence’ 
   Loss of independence 1 ‘I don’t go out so much since the  
    operation’ 
   Not returned to ‘normal’ 1 ‘Nothing was the same [after the  
    operation] and nothing still is’ 
   Not prepared for severity 1 ‘...it didn’t feel like a serious 
     operation’ 
   Increased awareness of own 
mortality 
1 ‘[I had a] sense of 
mortality…You’re  
    going to die one day’ 
   Positive impact on relationships 1 ‘Quality of life, in some respects, 
has improved. I spend more time 
interacting with family and value 
each day more than before.’ 
Symptoms 
   Lethargy 7 ‘Had no get up and go’ 
   Leg pain 7 ‘Aches in legs all the time now’ 
   Back pain 5 ‘I get lower back pain’ 
   Abdominal pain 4 ‘Had a routine examination 
(scan) for 
    stomach pains and found AAA’ 
   Buttock pain 4 ‘I had some pain in my left 
buttock 
    for some time’ 
   Calf pain 4 ‘I get aching in the legs 
sometimes –  
    claves below the knees’ 
   Low mood 4 ‘I got so depressed I had to have 
    antidepressants afterwards’ 
   Weight loss 4 ‘I lost a lot of weight…I’ve lost a  
    stone’ 
   Bruising 3 ‘I had a lot of bruising after – 
black 
    and blue to the knees’ 
   Leg swelling 3 ‘had a small amount of swelling 
and  
    the nurse said it would go 
down’ 
   Leg numbness 3 ‘I had this strange numbness’ 
   Decreased activity 2 ‘Physical activity is down – 
perhaps because I’m thinking I 
shouldn’t overdo it.’ 
   General weakness 2 ‘I feel a lot weaker to what I used 
to’ 
   Profuse sweating 2 ‘boiling hot, then sweating, then 
    chills’ 
   Poor appetite 2 ‘I would fantasize about food but 
if it was put in front of me I 
thought oh no’ 
   Poor balance 1 ‘The legs worked but felt 
different – 
    wobbly like I was drunk’ 
   Leg weakness 1 ‘The right leg is not as strong as 
the left. That’s new since the 
    operation’ 
   Leg heaviness 1 ‘...my right leg was really heavy, 
like a lump of lead’ 
   Poor cognitive function 1 ‘I put Christmas cards there and 
list there and couldn’t put the 
two together’ 
   Panic attacks 1 ‘I had panic attacks for a couple 
of weeks – and that’s not 
something I’ve ever had before’ 
   Hallucinations 1 ‘I had hallucinations I had been 
taken by a group and they were 
going to kill me’ 
   Changes in bowel function 1 ‘ I went to my doctor because I 
had a lot of flatulence that was  
 causing discomfort’ 
   Changes in urinary function 1 ‘...the next day I had waterwork 
    problems and still have’ 
   Wound problems 1 ‘…wound from second operation 
bled and bled and oozed 
congealed blood’ 
Treatment satisfaction 
   Unclear about risks (e.g. air travel) 6 ‘No one said what you can do 
and what you can’t’ 
   No choice in type of operation 6 ‘…the stent option wasn’t 
mentioned’ 
   Not clear how serious AAA was 
5 
‘No mention of taking it easy 
until after the operation…that 
was the first I knew how serious 
it was’ 
   Scans reassuring NOT a burden 
5 
‘It’s a pleasure coming here and 
being told you’re OK’ 
   Complications sometimes confusing 
3 
‘...was told I had a bent limb. I 
didn’t understand’ 
   Insufficient time to discuss 
diagnosis 
3 
‘There wasn’t a lot of time to ask 
    questions’ 
   Familial risks unclear 
3 
‘[The information leaflet] didn’t 
deal with the risks of having an  
    aneurysm – risk factors, 
genetics,  smoking’ 
   Felt unready to go home 3 ‘I didn’t feel ready to go home….I  
    was more knackered than I  
    expected to be’ 
   Little contact with surgeon 2 ‘Although you get the scan you 
don’t 
    automatically get [to see] the 
    consultant’ 
   No warning about side-effects 2 ‘There was a lack of information  
    about any likely adverse 
outcomes of the operation’ 
‘I had no appreciation of what I 
     would feel like after this 
operation’ 
   Poor understanding of AAA 2 ‘If the AAA bursts the chances of 
    surviving are pretty slim – but 
that is something I found out 
from the web, not from here’ 
‘How do they do it? Where does 
the blood go? I didn’t really get 
an answer I understood’ 
   Little time for consent 2 ‘It would have been better to 
have had the consent form 
sooner’ 
   Insufficient feedback about scans 2 ‘...when they scan you they don’t 
tell you [the results] – the 
operator of the scanner. You 
have to make an appointment’ 
   Hospital stay too long 1 ‘They kept me in for a day longer 
    than I felt was needed’ 
   Postoperative wound management  
       unclear 
1 ‘I wasn’t sure when to take the  
    dressings off’ 
‘Some hospitals don’t tell you 
what to do but say they will 
write to the GP and patients can 
talk to them’ 
   Insufficient follow-up/support 
1 
‘[I] objected to being cut out of 
the physiotherapists list without 
seeing me’ 
   Local follow-up would be preferable 1 ‘The only thing was can we have  
    scans at [local hospital] 
because it’s so much closer to 
home’ 
   Worried about radiation in theatre 1 ‘…worried…how much radiation 
I was going to get’ 
 
AAA, abdominal aortic aneurysm; GP, general practitioner. 
 
  
Table S2 Domains covered in the final version of the Aneurysm-Dependent Quality of Life 
Questionnaire (AneurysmDQoL) 
 
1. Leisure activities 
2. Working life 
3. Local or long distance journeys  
4. Holidays 
5. Physical ability 
6. Family life 
7. Friendships and social life  
8. Personal relationships 
9. Sex life 
10. Getting out and about 
11. Household tasks 
12. Being able to do things for others 
13. Enjoyment of food 
14. Feelings about the future  
15. Financial situation 
16. Dependence on others 
17. Health 
18. The amount people fuss or worry about me 
19. Energy 
20. Physical discomfort 
21. Anxiety 
22. Ability to think clearly, concentrate and/or remember things 
23. The amount I value each day 
 
  
 
Table S3 List of symptoms covered in the final version of the Aneurysm Symptom Rating 
Questionnaire (AneurysmSRQ) 
1. Tiredness 
2. Headaches 
3. Fevers 
4. Pain/discomfort in calves 
5. Pain/discomfort in thighs 
6. Pain/discomfort in groin 
7. Pain/discomfort in buttocks  
8. Pain/discomfort in back  
9. Abdominal pain/discomfort 
10. Wound problems 
11. Excessive bruising 
12. Minor illnesses 
13. Depression 
14. Panic  
15. Worried or nervous 
16. Irritable or angry  
17. Emotional or upset  
18. Difficulty concentrating  
19. Memory problems 
20. Difficulty thinking quickly and clearly 
21. Unsteady or uncoordinated  
22. Feeling dizzy, light-headed or faint  
23. Tingling or numbness in legs or feet  
24. Heaviness in legs 
25. Trembling (e.g. Of limbs) 
26. Weakness in legs 
27. Swollen legs 
28. Lost interest in sex 
29. Avoided sexual activity  
30. Problems with sexual function 
31. Excessive sweating  
32. Episodes of feeling too cold or too hot  
33. Sleep problems 
34. General weakness 
35. Poor appetite  
36. Weight  loss 
37. Weight gain 
38. Indigestion or heartburn  
39. Nausea or vomiting  
40. Excessive flatulence or belching 
41. Bloating  
42. Diarrhoea 
43. Constipation 
44. Difficulty urinating 
 
  
Table S4 Aspects of treatment covered in the final version of the Aneurysm Treatment 
Satisfaction Questionnaire (AneurysmTSQ) 
1. Aneurysm treatment (including monitoring) 
2. Convenience of treatment  (including monitoring) 
3. Bothered by any discomfort or pain   
4. Information provided  
5. Feedback about scan results   
6. Amount of support from nurses, doctors and other clinical staff  
7. Understanding of the treatment (including any operation/monitoring) 
8. Length of stay in hospital  
9. Side-effects of the treatment 
10. Postoperative follow-up  
11. Likely to encourage others to have the same kind of treatment  
 
 
 
